JPS53139730A - Pharmaceutical composition and method - Google Patents

Pharmaceutical composition and method

Info

Publication number
JPS53139730A
JPS53139730A JP5383078A JP5383078A JPS53139730A JP S53139730 A JPS53139730 A JP S53139730A JP 5383078 A JP5383078 A JP 5383078A JP 5383078 A JP5383078 A JP 5383078A JP S53139730 A JPS53139730 A JP S53139730A
Authority
JP
Japan
Prior art keywords
pharmaceutical composition
pharmaceutical
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP5383078A
Other languages
English (en)
Inventor
Kuremaa Borufuganku
Haintsu Biyutsuheru Kaaru
Purenperu Manfuretsuto
Haraa Ingo
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer AG
Original Assignee
Bayer AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer AG filed Critical Bayer AG
Publication of JPS53139730A publication Critical patent/JPS53139730A/ja
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/61—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
    • C07C45/67—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton
    • C07C45/68—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms
    • C07C45/70—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms by reaction with functional groups containing oxygen only in singly bound form
    • C07C45/71—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms by reaction with functional groups containing oxygen only in singly bound form being hydroxy groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/20—Unsaturated compounds containing keto groups bound to acyclic carbon atoms
    • C07C49/255—Unsaturated compounds containing keto groups bound to acyclic carbon atoms containing ether groups, groups, groups, or groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Oncology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
JP5383078A 1977-05-10 1978-05-08 Pharmaceutical composition and method Pending JPS53139730A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19772720868 DE2720868A1 (de) 1977-05-10 1977-05-10 Antimikrobielle mittel

Publications (1)

Publication Number Publication Date
JPS53139730A true JPS53139730A (en) 1978-12-06

Family

ID=6008463

Family Applications (2)

Application Number Title Priority Date Filing Date
JP5383078A Pending JPS53139730A (en) 1977-05-10 1978-05-08 Pharmaceutical composition and method
JP5382978A Pending JPS53139729A (en) 1977-05-10 1978-05-08 Pharmaceutical composition and method

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP5382978A Pending JPS53139729A (en) 1977-05-10 1978-05-08 Pharmaceutical composition and method

Country Status (7)

Country Link
US (1) US4233311A (ja)
JP (2) JPS53139730A (ja)
AU (1) AU521768B2 (ja)
BE (1) BE866832A (ja)
DE (1) DE2720868A1 (ja)
FR (1) FR2390161A1 (ja)
GB (1) GB1585940A (ja)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2925687A1 (de) * 1979-06-26 1981-01-22 Basf Ag Triazolylglykolether enthaltende mittel zur regulierung des pflanzenwachstums
DE2931756A1 (de) * 1979-08-04 1981-02-19 Bayer Ag Antimikrobielle mittel
DE2931778A1 (de) * 1979-08-04 1981-02-19 Bayer Ag Antimikrobielle mittel
DE2931665A1 (de) * 1979-08-04 1981-02-19 Bayer Ag Imidazolyl-enolether, verfahren zu ihrer herstellung und ihre verwendung als fungizide
DE2931755A1 (de) * 1979-08-04 1981-02-19 Bayer Ag 1,2,4-triazolyl-enolether, verfahren zu ihrer herstellung und ihre verwendung als fungizide
DE3070778D1 (en) * 1979-08-11 1985-07-25 Bayer Ag Antimycotic agents with enhanced release of the active ingredients
DE3000140A1 (de) 1980-01-04 1981-07-09 Basf Ag, 6700 Ludwigshafen Fungizide azolyl-silyl-glykolether, ihre herstellung und verwendung
DE3021551A1 (de) * 1980-06-07 1981-12-24 Bayer Ag, 5090 Leverkusen 4-substituierte 1-azolyl-1-phenoxy-3,3-dimethyl-butan-2-one und -ole, verfahren zu ihrer herstellung und ihre verwendung als fungizide
DE3202604A1 (de) * 1982-01-27 1983-08-04 Bayer Ag, 5090 Leverkusen Ether-derivate von substituierten 1-hydroxyalkyl-azolen, verfahren zu ihrer herstellung sowie ihre verwendung als fungizide und pflanzenwachstumsregulatoren
DE3234624A1 (de) * 1982-09-18 1984-03-22 Bayer Ag, 5090 Leverkusen Fungizide mittel
DE3628545A1 (de) * 1985-09-23 1987-04-23 Hoechst Ag Arylmethylazole und deren salze, verfahren zu ihrer herstellung, sie enthaltende mittel und ihre verwendung
DE3707151A1 (de) * 1987-03-06 1988-09-15 Hoechst Ag 1-(1-aryl-2-hydroxy-ethyl)-imidazole und deren salze, verfahren zu ihrer herstellung, diese verbindungen enthaltende arzneimittel und ihre verwendung
DE60234057D1 (de) 2001-07-25 2009-11-26 Raptor Pharmaceutical Inc Zusammensetzungen und verfahren zur modulation des transports durch die blut-hirn-schranke
EP2392258B1 (en) 2005-04-28 2014-10-08 Proteus Digital Health, Inc. Pharma-informatics system
US8795627B2 (en) 2007-03-21 2014-08-05 Raptor Pharmaceuticals Inc. Treatment of liver disorders by administration of RAP conjugates
SE532906C2 (sv) * 2008-09-23 2010-05-04 Scania Cv Abp Hydrolyskatalysator med större kanaltvärsnitt i den perifera delen än i den centrala delen samt sätt för hydrolys av ett urinämne
AU2010216512B2 (en) 2009-02-20 2016-06-30 2-Bbb Medicines B.V. Glutathione-based drug delivery system
WO2010129819A2 (en) 2009-05-06 2010-11-11 Laboratory Skin Care, Inc. Dermal delivery compositions comprising active agent-calcium phosphate particle complexes and methods of using the same
US20120077778A1 (en) 2010-09-29 2012-03-29 Andrea Bourdelais Ladder-Frame Polyether Conjugates

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3658813A (en) * 1970-01-13 1972-04-25 Janssen Pharmaceutica Nv 1-(beta-aryl-beta-(r-oxy)-ethyl)-imidazoles
DE2325156A1 (de) * 1973-05-18 1974-12-05 Bayer Ag Fungizide und mikrobizide mittel
DE2333355C2 (de) * 1973-06-30 1984-01-19 Bayer Ag, 5090 Leverkusen Antimikrobielle Mittel
DE2350123C2 (de) * 1973-10-05 1983-04-14 Bayer Ag, 5090 Leverkusen 1-Propyl-imidazol-Derivate und deren Salze, Verfahren zu ihrer Herstellung und ihre Verwendung als Fungizide
DE2350124A1 (de) * 1973-10-05 1975-04-10 Bayer Ag Antimikrobielle mittel

Also Published As

Publication number Publication date
JPS53139729A (en) 1978-12-06
GB1585940A (en) 1981-03-11
AU521768B2 (en) 1982-04-29
FR2390161A1 (fr) 1978-12-08
AU3580678A (en) 1979-11-08
BE866832A (fr) 1978-11-09
FR2390161B1 (ja) 1980-07-11
US4233311A (en) 1980-11-11
DE2720868A1 (de) 1978-11-23

Similar Documents

Publication Publication Date Title
JPS5464695A (en) Substance composition and method
NZ188872A (en) 9-(-heteroarylamino-alkylamino)-erthromycins and pharmaceutical compositions
JPS54135776A (en) Pharmaceutical composition and method
JPS5416453A (en) Composition and method
JPS53113007A (en) Pharmaceutical composition
JPS53109934A (en) Pharmaceutical composition
JPS5455568A (en) 11substituted imidazoles and pharmaceutical composition
JPS549265A (en) Composition and method
NZ188170A (en) Propenylamines and pharmaceutical compositions
JPS53139730A (en) Pharmaceutical composition and method
NZ187794A (en) 1-acyl-2-cynanoaziridines and immunestimulating pharmaceutical compositions
NZ189296A (en) N-substituted-omega-aminoalkanoyl-omega-aminoalkanoic acids and pharmaceutical compositions
NZ188531A (en) W-mercapto-propionamides and pharmaceutical compositions
JPS5492953A (en) Composition and method
GB2021409B (en) Pharmaceutical composition
GB2002229B (en) Pharmaceutical composition
JPS53145905A (en) Pharmaceutical composition and production thereof
JPS5470255A (en) Nnbenzylanthracycline and pharmaceutical composition
NZ187851A (en) 3-substituted amino- 4-oxo-4h-1-benzopyranes and pharmaceutical compositions
ZA785347B (en) Pharmaceutical compositions and method of use
JPS53108996A (en) 33thiadiazolylthiomethyll77 aminothiazolylacetamide cephalospolanate process for preparing same and pharmaceutical composition
JPS53101520A (en) Pharmaceutical composition
NZ187337A (en) 5-phenyl-1h-3-benzazepines and pharmaceutical compositions
JPS5492952A (en) Composition and method
PH13130A (en) Pharmaceutical composition and method